pharma.markets

  • HOME
  • Imprint

guidance

HHS Announces New Laboratory Data Reporting Guidance for COVID-19 Testing

09/06/2020 MaP 0

Today, the U.S. Department of Health and Human Services (HHS) announced new Guidance that specifies what additional data must be reported to HHS by laboratories […]

Coronavirus: EU Commission welcomes ECDC guidance on surveillance of COVID-19 in long-term care facilities in the EU

19/05/2020 MaP 0

Today, the European Centre for Disease Prevention and Control (ECDC) published guidance to Member States for the development of COVID-19 surveillance in long-term care facilities. […]

Tourism and transport: EU Commission’s guidance on how to safely resume travel and reboot Europe’s tourism in 2020 and beyond

13/05/2020 MaP 0

Today, the Commission presents a package of guidelines and recommendations to help Member States gradually lift travel restrictions and allow tourism businesses to reopen, after […]

EU Commission publishes guidance on coronavirus-related humanitarian aid to Syria despite sanctions

12/05/2020 MaP 0

The European Commission has published detailed guidance on how coronavirus-related humanitarian aid can be sent to countries and areas around the world that are subject […]

Coronavirus: EU Commission issues guidance to mitigate clinical trial disruption in the EU

28/04/2020 MaP 0

Today, the Commission has published guidance to ensure that clinical trials can continue taking place in the EU during the coronavirus pandemic. The aim is […]

Coronavirus: EU guidance for a safe return to the workplace

24/04/2020 MaP 0

The European Agency for Safety and Health at Work (EU-OSHA)has issued today guidance on coming back to work after coronavirus. The European Commission attaches the […]

Coronavirus: EU Commission publishes guidance to ensure full data protection standards of apps fighting the pandemic

17/04/2020 MaP 0

The Commission has published guidance on the development of new apps that support the fight against coronavirus in relation to data protection. The development of […]

EU Guidance on the collection and transfusion of convalescent COVID-19 plasma

10/04/2020 MaP 0

Plasma transfusion is a potentially promising therapy for COVID-19 patients that can be made widely available at relatively short notice by blood services across the […]

Coronavirus disease 2019 (COVID-19) and supply of substances of human origin in the EU/EEA

25/03/2020 MaP 0

Blood, tissues, cells and organs / COVID-19 as PDF download ECDC guidance document on COVID-19 and Substances of Human Origin (SoHO) https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-supply-substances-human-origin.pdf © European Centre […]

Translation

en English
ar Arabiczh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianja Japaneseko Koreanpt Portugueseru Russianes Spanish

Search

Categories

  • Age.related Degeneration
  • Animal health
  • Asthma
  • Cancer
  • COVID-19
  • EIB
  • EU
  • FCPA Investigations
  • FDA
  • Finance
  • Humanitarian Aid
  • Imprint
  • Influenza
  • MS
  • News
  • Research
  • Rheumatology
  • Space Science
  • UN
  • Vaccines

Reports

  • Roche announces results from Evrysdi (risdiplam) study in infants with Type 1 spinal muscular atrophy (SMA) published in New England Journal of Medicine
  • Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants
  • EU doubles contribution to COVAX to €1 billion to ensure safe and effective vaccines for low and middle-income countries
  • In Vitro Study Published in The New England Journal of Medicine
  • Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®

Archive

  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
  • Roche announces results from Evrysdi (risdiplam) study in infants with Type 1 spinal muscular atrophy (SMA) published in New England Journal of Medicine

    25/02/2021 0
  • Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants

    25/02/2021 0
  • Copyright European Commission 2021

    EU doubles contribution to COVAX to €1 billion to ensure safe and effective vaccines for low and middle-income countries

    20/02/2021 0
  • In Vitro Study Published in The New England Journal of Medicine

    17/02/2021 0
  • Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®

    17/02/2021 0
Archives
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
TAGS
affected africa aid biontech cancer commission companies coronavirus covid-19 covid19 crisis economy elpais.com eu europe european fda fight food global guarantee health hygiene italy links medical merck novartis pandemic pfizer production products recommendations region response roche safety scheme sector spain state statistics stats support vaccine

Copyright © 2021 | WordPress Theme by MH Themes